<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0047">
 <label>47</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Martinez</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Castro</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dorronsoro</surname>
    <given-names>I</given-names>
   </name>, 
   <name name-style="western">
    <surname>Alonso</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation</article-title>. 
  <source>Med Res Rev</source>
  <year>2002</year>;
  <volume>22</volume>:
  <fpage>373</fpage>â€“
  <lpage>84</lpage>.
  <pub-id pub-id-type="pmid">12111750</pub-id>
 </mixed-citation>
</ref>
